PF-Atlas › Clinical Trials › NCT00528190

Treatment of Aspergillus Fumigatus in Patients With Cystic Fibrosis

Itraconazole · Phase 4

Registry ID

NCT00528190

Phase

Phase 4

Status

Completed

Drug / intervention

Itraconazole

Sponsor

Ottawa Hospital Research Institute

Start

2007-10

Enrollment

Locations

About this trial

This clinical trial will attempt to determine whether we can improve clinical outcomes for patients with cystic fibrosis who are infected with a fungus called Aspergillus fumigatus.

View NCT00528190 on ClinicalTrials.gov →

Explore related

All Itraconazole trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00528190 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.